Annual Shareholders Equity
-$67.94 M
+$25.28 M+27.12%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual stockholders equity is -$67.94 million, with the most recent change of +$25.28 million (+27.12%) on December 31, 2023.
- During the last 3 years, CTNM annual shareholders equity has risen by +$2.96 million (+4.17%).
- CTNM annual shareholders equity is now at all-time high.
Performance
CTNM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$210.23 M
-$7.28 M-3.34%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly stockholders equity is $210.23 million, with the most recent change of -$7.28 million (-3.34%) on September 30, 2024.
- Over the past year, CTNM quarterly shareholders equity has increased by +$278.16 million (+409.45%).
- CTNM quarterly shareholders equity is now -3.34% below its all-time high of $217.50 million, reached on June 30, 2024.
Performance
CTNM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTNM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.1% | +409.4% |
| 3 y3 years | +4.2% | +325.5% |
| 5 y5 years | +4.2% | +325.5% |
CTNM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.1% | -3.3% | +325.5% |
| 5 y | 5-year | at high | +27.1% | -3.3% | +325.5% |
| alltime | all time | at high | +27.1% | -3.3% | +325.5% |
Contineum Therapeutics Class A Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $210.23 M(-3.3%) |
| Jun 2024 | - | $217.50 M(-387.6%) |
| Mar 2024 | - | -$75.63 M(+11.3%) |
| Dec 2023 | -$67.94 M | -$67.94 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$61.14 M(-34.4%) |
| Dec 2022 | -$93.21 M(+31.5%) | - |
| Dec 2022 | - | -$93.21 M |
| Dec 2021 | -$70.89 M | - |
FAQ
- What is Contineum Therapeutics Class A annual stockholders equity?
- What is the all time high annual shareholders equity for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual shareholders equity year-on-year change?
- What is Contineum Therapeutics Class A quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly shareholders equity year-on-year change?
What is Contineum Therapeutics Class A annual stockholders equity?
The current annual shareholders equity of CTNM is -$67.94 M
What is the all time high annual shareholders equity for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual stockholders equity is -$67.94 M
What is Contineum Therapeutics Class A annual shareholders equity year-on-year change?
Over the past year, CTNM annual stockholders equity has changed by +$25.28 M (+27.12%)
What is Contineum Therapeutics Class A quarterly stockholders equity?
The current quarterly shareholders equity of CTNM is $210.23 M
What is the all time high quarterly shareholders equity for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly stockholders equity is $217.50 M
What is Contineum Therapeutics Class A quarterly shareholders equity year-on-year change?
Over the past year, CTNM quarterly stockholders equity has changed by +$278.16 M (+409.45%)